Hemodialysis and Peritoneal Dialysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Hemodialysis, Peritoneal Dialysis), By Product (Devices, Consumables, Services), By End user (Home-based, Hospital-based), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 80.12 Billion
CAGR (2026-2031)	6.95%
Fastest Growing Segment	Hemodialysis
Largest Market	North America
Market Size (2031)	USD 119.91 Billion

Market Overview

The Global Hemodialysis and Peritoneal Dialysis Market will grow from USD 80.12 Billion in 2025 to USD 119.91 Billion by 2031 at a 6.95% CAGR. Hemodialysis functions by utilizing an external machine to filter blood, whereas peritoneal dialysis employs the peritoneum within the abdomen as an internal natural filter. The global market is primarily propelled by the escalating prevalence of end-stage renal disease, which is intrinsically linked to the aging global population and the rising incidence of lifestyle-dependent conditions such as diabetes and hypertension. These demographic and epidemiological factors fundamentally necessitate life-sustaining renal replacement therapies, driving sustained demand independent of technological shifts. According to the International Society of Nephrology, in 2023, approximately 850 million individuals globally were estimated to be affected by chronic kidney disease, underscoring the critical health burden supporting this sector.

A significant challenge impeding market expansion is the acute shortage of skilled healthcare professionals, including nephrologists and specialized dialysis nurses, required to administer these complex treatments. This workforce scarcity restricts the operational capacity of dialysis centers and limits patient access to care, particularly in developing regions where infrastructure is already strained. Furthermore, the high recurring costs associated with long-term therapy and inconsistent reimbursement policies across different jurisdictions create substantial economic barriers that hinder the broader accessibility and growth of dialysis services.

Key Market Drivers

The escalating global prevalence of chronic kidney disease and end-stage renal disease constitutes the primary catalyst for market expansion, fundamentally driven by the rising incidence of diabetes and hypertension. As lifestyle-dependent conditions accelerate the progression of renal failure, they create an unavoidable and sustained demand for life-sustaining renal replacement therapies, particularly among the aging geriatric population. This demographic shift necessitates robust operational capacities within dialysis networks to manage the increasing patient volume. According to DaVita Inc., February 2024, in the '4th Quarter 2023 Results' report, the company provided dialysis services to a total of approximately 250,200 patients across its network by the end of 2023, illustrating the sheer scale of the population requiring daily or weekly life-support treatments.

Concurrently, the growing adoption and preference for cost-effective home-based dialysis modalities is reshaping the service landscape. Healthcare systems and insurance providers are increasingly incentivizing home dialysis to alleviate the financial burden associated with traditional in-center treatments, while patients favor the modality for its convenience and improved quality of life. Technological advancements in portable devices have further facilitated this transition, allowing for broader patient uptake. According to Fresenius Medical Care, March 2024, in the 'Non-financial Group Report 2023', the number of their patients receiving dialysis at home worldwide reached 31,258 as of December 31, 2023, highlighting the segment's steady expansion. This shift is supported by substantial investment in renal care infrastructure; according to Baxter International, in 2024, the company reported sales from continuing operations in the U.S. alone totaled $7.00 billion for the full year 2023, reflecting the significant capital flowing into the broader renal care and medical therapies market.

Download Free Sample Report

Key Market Challenges

The acute shortage of skilled healthcare professionals represents a critical bottleneck restricting the expansion of the global hemodialysis and peritoneal dialysis market. While the demand for renal replacement therapies continues to rise due to demographic shifts, the operational capacity of dialysis centers is frequently capped by the unavailability of qualified staff rather than a lack of equipment. This workforce deficit directly impedes the establishment of new facilities and reduces patient turnover in existing clinics, effectively stalling revenue generation in high-demand areas. Consequently, manufacturers and service providers face a ceiling on growth as the adoption of their technologies depends heavily on the availability of trained personnel to administer care.

According to the International Society of Nephrology, in 2024, approximately 64% of surveyed countries reported a shortage of nephrologists, while 58% reported a deficit in dialysis nurses. This scarcity is particularly detrimental in emerging economies where the gap between patient volume and available clinical expertise is widest. By limiting the delivery of essential treatments, this human resource crisis prevents the market from fully capitalizing on the escalating prevalence of chronic kidney disease, thereby dampening overall industry momentum.

Key Market Trends

The emergence of sustainable and green dialysis technologies is rapidly becoming a critical trend as the industry seeks to mitigate the high environmental footprint associated with traditional renal care. Conventional hemodialysis processes are resource-intensive, consuming vast quantities of water and electricity, which drives manufacturers and service providers to engineer eco-friendly systems capable of minimizing waste without compromising clinical quality. This shift is characterized by the implementation of water conservation protocols and energy-efficient infrastructure to align with global environmental, social, and governance (ESG) standards. According to DaVita Inc., May 2025, in the '2024 Community Care' report, the company saved more than 75 million gallons of water through water efficiency projects in 2024, illustrating the tangible impact of these sustainability initiatives on operational resource management.

Concurrently, the development of wearable and portable dialysis devices is fundamentally altering the technological framework of renal replacement therapy by decoupling treatment from heavy, stationary infrastructure. Unlike the general shift toward home care driven by reimbursement models, this trend focuses specifically on the engineering innovation that allows for compact, all-in-one consoles to offer hospital-grade efficacy in mobile formats. These advancements are gaining traction not only for their patient-centric design but also for their versatility in acute and sub-acute clinical settings where space and mobility are premium assets. According to Outset Medical, Inc., February 2025, in the 'Fourth Quarter and Full Year 2024 Financial Results', the installed base for its Tablo console reached nearly 6,000 units, representing a 10 percent growth in 2024, signaling a robust market appetite for these next-generation technological platforms.

Segmental Insights

Hemodialysis is identified as the fastest growing segment in the global market due to the escalating prevalence of end-stage renal disease and the consequent demand for effective renal replacement therapies. This expansion is supported by the increasing availability of specialized dialysis centers and significant improvements in home-based equipment which enhance patient accessibility. Additionally, supportive reimbursement frameworks and guidelines from entities such as the Centers for Medicare and Medicaid Services have facilitated broader treatment adoption. The strong clinical preference for hemodialysis in managing complex renal failure cases further drives this rapid sectoral development.

Regional Insights

North America commands the largest share of the global hemodialysis and peritoneal dialysis market, driven by the rising incidence of End-Stage Renal Disease and robust healthcare spending. The dominance of this region is largely attributed to favorable reimbursement structures established by the Centers for Medicare & Medicaid Services, which facilitate widespread access to renal care services. Additionally, the concentrated presence of key market manufacturers facilitates rapid adoption of new treatment modalities. These combined factors create a stable environment for sustained market leadership across the continent.

Recent Developments

• In November 2024, Quanta Dialysis Technologies confirmed that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its proprietary dialysis system in home settings. This regulatory milestone positioned the company as the sole provider of a high dialysate flow system capable of delivering 500 mL/min across the entire care continuum for patients with end-stage renal disease. The Chief Executive Officer of Quanta Dialysis Technologies stated that this approval would allow patients to transition seamlessly to home-based care, addressing a critical gap in the Global Hemodialysis and Peritoneal Dialysis Market where few patients currently utilize home hemodialysis.
• In August 2024, Diality Inc. secured 510(k) clearance from the U.S. FDA for its Moda-flx Hemodialysis System, a compact and mobile platform intended for use in professional care settings. The system was developed to offer clinicians greater flexibility by incorporating variable flow rate ranges and integrated reverse osmosis water filtration into a user-friendly interface. The Chief Executive Officer of Diality Inc. highlighted that this clearance marked a paradigm shift in kidney disease treatment, aiming to reduce the operational burden on care providers. The device supports various treatment modalities, including intermittent hemodialysis and sustained low-efficiency dialysis, expanding options within the Global Hemodialysis and Peritoneal Dialysis Market.
• In April 2024, Outset Medical entered into a multi-year strategic partnership with U.S. Renal Care to expand access to home hemodialysis across the United States. This collaboration focused on utilizing Outset Medical's Tablo Hemodialysis System as a primary option for home-based treatment in the 33 states where U.S. Renal Care operates. The agreement aimed to accelerate the adoption of home dialysis by leveraging the system's ease of use, which requires only a standard electrical outlet and tap water. Executives from both organizations emphasized that this alliance would enhance patient choice and improve clinical outcomes by simplifying the complexity of traditional dialysis in the Global Hemodialysis and Peritoneal Dialysis Market.
• In February 2024, Fresenius Medical Care announced that it obtained 510(k) clearance from the U.S. FDA for its 5008X Hemodialysis System. This approval enabled the company to introduce its high-volume hemodiafiltration therapy, which was already widely utilized in Europe, to the United States market. The system was designed to improve outcomes for individuals with kidney disease by removing excess water and toxins more effectively than traditional methods. The Chief Executive Officer of Fresenius Medical Care noted that this clearance represented a significant step in bringing a new standard of care to one of the world's largest healthcare markets, reinforcing the company's leadership in the Global Hemodialysis and Peritoneal Dialysis Market.

Key Market Players

• Baxter International Inc
• B. Braun Melsungen AG
• Fresenius Medical Care AG
• Medtronic, Inc
• Asahi Kasei Medical Co., Ltd
• Nipro Corp
• DaVita Inc
• Becton Dickinson & Co
• Nikkiso Co., Ltd
• Terumo Corporation

By Type	By Product	By End user	By Region
Hemodialysis Peritoneal Dialysis	Devices Consumables Services	Home-based Hospital-based	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Hemodialysis and Peritoneal Dialysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hemodialysis and Peritoneal Dialysis Market, By Type:

• Hemodialysis
• Peritoneal Dialysis

• Hemodialysis and Peritoneal Dialysis Market, By Product:

• Devices
• Consumables
• Services

• Hemodialysis and Peritoneal Dialysis Market, By End user:

• Home-based
• Hospital-based

• Hemodialysis and Peritoneal Dialysis Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE